The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.
about
Challenges in the Management of Geriatric Obesity in High Risk PopulationsLatest consensus and update on protein-energy wasting in chronic kidney diseaseAdministered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysisAccuracy and limitations of the diagnosis of malnutrition in dialysis patientsDeveloping an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients.Donor race and outcomes in kidney transplant recipientsEstimated glomerular filtration rate at reinitiation of dialysis and mortality in failed kidney transplant recipients.Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney diseaseSerum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature.Dialysis modality and outcomes in kidney transplant recipientsAssociation of pretransplant serum phosphorus with posttransplant outcomes.Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patientsHigh platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patientsAssociations of pretransplant weight and muscle mass with mortality in renal transplant recipients.Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients.Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.Physical activity and metabolic health in chronic kidney disease: a cross-sectional study.Association between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study.Association of Alternative Approaches to Normalizing Peritoneal Dialysis Clearance with Mortality and Technique Failure: A Retrospective Analysis Using the United States Renal Data System-Dialysis Morbidity and Mortality Study, Wave 2.Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors.Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study.Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis.Extremes of body mass index and mortality among Asian peritoneal dialysis patients.Higher recipient body mass index is associated with post-transplant delayed kidney graft function.Timing of dialysis initiation in transplant-naive and failed transplant patientsSarcopenia with limited mobility: an international consensus.Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis.Survival and predictive factors of lethality in hemodialysis: D/I polymorphism of the angiotensin I-converting enzyme and of the angiotensinogen M235T genesThe obesity paradox in acute coronary syndrome: a meta-analysisNovel equations to estimate lean body mass in maintenance hemodialysis patientsDietary restriction and exercise for diabetic patients with chronic kidney disease: a systematic review.Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States.The association between body mass index and mortality in incident dialysis patients.Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status.Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis.Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation.Body mass index-mortality paradox in hemodialysis: can it be explained by blood pressure?Obesity, metabolic health, and the risk of end-stage renal disease.Body composition and coronary heart disease mortality--an obesity or a lean paradox?
P2860
Q26751482-90532B19-44F2-44A2-8370-6A600AFE7766Q27027875-62FEE12B-4B48-4E52-9576-29A817E83378Q30408489-C3CEF5DB-6EED-48D3-8964-4E507A641D3BQ30410840-4D22BA70-C754-439F-BABE-6BD1C72C2DFEQ30413995-49F0EC62-EA49-44F8-8D26-DC9EA3C06CDEQ30415457-B249CC22-8AC9-4F8D-9958-99B4CB4DB4B9Q30418567-2B501079-C6D6-4FA0-B8CE-6D11BDAD3373Q30418571-E9FB34F8-71E9-4799-BA14-D782BD370E02Q30422206-EEC799F8-01AC-418E-AD45-214DC0B4A7A4Q30422546-7F4C61CC-C73C-4DD3-BB00-B162F011072BQ30424192-E6FD2FE1-5A4E-4E0E-BF3B-74DD48750543Q30424662-5DFF2343-5C16-4242-9E34-BAB8469132F1Q30425078-AA0B4805-DAAE-4242-91A0-F5080CE5E64FQ30426610-81DEBF85-366B-4CA2-9322-28C861BC5402Q30427039-29DC1B8D-6B9A-43DD-984A-16E2D4FD8BFCQ30427552-D2CD1023-C1F7-4D10-986B-C6078DBE2B6CQ30829502-817FBAC4-1218-4A2D-AD09-FAA7BE5A3BB0Q31073301-06CAE44D-06A0-4149-B0D0-679749E5D876Q31133575-A02FFAB3-09C9-4C01-B9BC-DEF5DE5F6A86Q33610729-1768C0B9-2936-4C05-BA89-D46E5C95F432Q33723012-B94D8476-EA5F-4ADB-8206-B633DD772927Q33730477-B6B92997-24D9-4730-9BBA-43DD36B55E51Q33829253-483DFA1E-45E4-4ED8-B603-39BAC108271CQ33837623-177343AC-AF86-45C1-97D3-3301DDB43F10Q33848144-EC3E3B6F-BC90-4FC1-9980-B38B5CA59D83Q33919866-7242983B-20BC-4374-8EA3-4BFA98F323F3Q34189767-3843A93A-BF31-4F3E-81C1-2BB6790AB13EQ34196237-5D5C9C4B-9170-430D-8F7E-95489B22166BQ34319908-3E768670-1F3A-4AD0-BE11-5D2A0E15B6B1Q34445415-DF85165B-3B12-4EB1-8D46-897C1CC22B2AQ34518515-806F873A-D698-4EEB-97FF-AE7DD7285E3EQ34572119-81B963C4-266C-4705-ACE6-BF35F2AF57C9Q34629690-DB6D9715-A169-46FD-A160-3F605988E4BBQ34712804-46CDBBC4-C6FF-4A24-A4B3-3DB3F4EB037EQ34927010-304BBA6E-CDBC-4863-8E66-F8713ACACC24Q35182504-18D2CFFE-3D9F-440E-88AB-368FA8A59460Q35459884-4C9B0CAB-994D-4F78-B1FE-573C7FC09A6EQ35621936-6B5DEF4E-1426-43DC-953B-6C1E1136C2F8Q35667706-52628F3A-9245-4BDF-8553-AEF0397223E6Q35671806-85269419-D0F5-4061-89BF-C3EDD1ADD275
P2860
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The obesity paradox and mortal ...... tients receiving hemodialysis.
@ast
The obesity paradox and mortal ...... tients receiving hemodialysis.
@en
The obesity paradox and mortal ...... tients receiving hemodialysis.
@nl
type
label
The obesity paradox and mortal ...... tients receiving hemodialysis.
@ast
The obesity paradox and mortal ...... tients receiving hemodialysis.
@en
The obesity paradox and mortal ...... tients receiving hemodialysis.
@nl
prefLabel
The obesity paradox and mortal ...... tients receiving hemodialysis.
@ast
The obesity paradox and mortal ...... tients receiving hemodialysis.
@en
The obesity paradox and mortal ...... tients receiving hemodialysis.
@nl
P2093
P2860
P50
P356
P1476
The obesity paradox and mortal ...... tients receiving hemodialysis.
@en
P2093
Allen R Nissenson
Antigone Oreopoulos
Jennie Jing
Mahesh Krishnan
Nazanin Noori
P2860
P304
P356
10.4065/MCP.2010.0336
P407
P577
2010-11-01T00:00:00Z